Corrigendum to ‘IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?’ Clinical Biochemistry 61 (2018) 34–39
Petrova, Lucie, Vrbacky, Filip, Lanska, Miriam, Zavrelova, Alzbeta, Zak, Pavel, Hrochova, KaterinaLanguage:
english
Journal:
Clinical Biochemistry
DOI:
10.1016/j.clinbiochem.2018.10.005
Date:
October, 2018
File:
PDF, 183 KB
english, 2018